Vizient, Inc. Applauds FDA’s Heightened Focus on Preventing Drug Shortages
IRVING, Texas--(BUSINESS WIRE)--Jul 13, 2018--Vizient, Inc. applauds the U.S. Food and Drug Administration (FDA) for forming a new drug shortages task force and advancing long-term solutions to prevent shortages.
Stable and reliable supply, along with cost and safety, are always top priorities for Vizient. In addition to regular communication and education to our health care members, for years we’ve worked to mitigate the impact of shortages and price spikes through innovative contracting strategies and alternative drug therapies, as well as by being actively involved in advocating for legislative language to encourage competition.
“Access to affordable drugs is one of the most critical challenges facing health care today,” says Dan Kistner, senior vice president, pharmacy solutions at Vizient. “For over a decade, drug shortages have plagued hospitals and become a routine obstacle around which providers have had to navigate. It is a natural extension of Vizient’s mission to work collaboratively with all stakeholders to find innovative solutions to prevent drug shortages.” Vizient is committed to working with the FDA and other stakeholders to improve the safety and reliability of the supply chain.
Vizient is the nation’s largest health care performance improvement company serving a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health care delivery networks and non-acute health care providers.
About Vizient, Inc.
Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents approximately $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as MedAssets’ Spend and Clinical Resource Management (SCM) segment, including Sg2, which was acquired in 2016. In 2018, Vizient again received a World’s Most Ethical Company designation from the Ethisphere Institute. Vizient’s headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit www.vizientinc.com as well as our newsroom, blog, Twitter, LinkedIn and YouTube pages for more information about the company.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005297/en/
CONTACT: Vizient, Inc.
Angie Boliver, 972-830-7961
KEYWORD: UNITED STATES NORTH AMERICA TEXAS
INDUSTRY KEYWORD: PRACTICE MANAGEMENT HEALTH HOSPITALS PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM PHARMACEUTICAL OTHER POLICY ISSUES PUBLIC POLICY FDA MEDICAL SUPPLIES
SOURCE: Vizient, Inc.
Copyright Business Wire 2018.
PUB: 07/13/2018 10:51 AM/DISC: 07/13/2018 10:51 AM